Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
about
An automated data-driven DSP development approach for glycoproteins from yeast.The future of protein scaffolds as affinity reagents for purification.Continuous counter-current chromatography for capture and polishing steps in biopharmaceutical production.Performance optimization of continuous countercurrent tangential chromatography for antibody capture.Development of adsorptive hybrid filters to enable two-step purification of biologics.Understanding and modeling retention of mammalian cells in fluidized bed centrifuges.Purification of Monoclonal Antibodies Using a Fiber Based Cation-Exchange Stationary Phase: Parameter Determination and Modeling.Metabolic Control in Mammalian Fed-Batch Cell Cultures for Reduced Lactic Acid Accumulation and Improved Process RobustnessFc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides.Design of a novel continuous flow reactor for low pH viral inactivation.Advanced model-based control strategies for the intensification of upstream and downstream processing in mAb production.Antibody purification from CHO cell supernatant using new multimodal membranes.Continuous bind-and-elute protein A capture chromatography: Optimization under process scale column constraints and comparison to batch operation.Fed-Batch CHO Cell Culture for Lab-Scale Antibody Production.Immobilized metal affinity cryogel-based high-throughput platform for screening bioprocess and chromatographic parameters of His6-GTPase.Process Analytical Technology for Advanced Process Control in Biologics Manufacturing with the Aid of Macroscopic Kinetic Modeling.Evolving trends in mAb production processes.Membrane chromatography for protein purifications from ligand design to functionalizationIntegrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel AntivenomsAccelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation
P2860
Q38641433-8D10413A-50E3-45C5-91AE-E2D3FA70C812Q38827102-567CC694-8CBF-4AED-80C1-EF30B0670EE2Q38845449-B71D6F29-B615-442A-A69B-CC419CA97E56Q39969408-A57CB1C0-413B-45F2-9F7E-8A434264B0F1Q40435773-54270D0E-3581-4D68-8FFF-E5F5CD287BE7Q40548980-A09E0BD1-9DA1-403F-AEC3-1AE65C34953CQ41704491-8CAA8327-E3C9-4EFD-90CE-90B010EFB2C6Q41704579-3271FC9E-B292-4CEE-99E8-8227CDD28922Q42225453-23D4C1DE-EA37-4E82-A176-0770379A53D6Q46001009-BA4D036F-46DF-4E52-AE6A-D4530D10678CQ47396419-9CCDE244-90B0-46C8-917F-11A049EDF59CQ47428072-74C6BDB0-ECEA-4CDD-97D3-0F31BB38C773Q47816230-34829AC1-B804-4FBF-9160-77083DF88E45Q50046034-54D9F806-0DC8-438A-AA0C-E415AA9D0A29Q50963465-A6D1DF98-C2AE-4453-908A-592A9F158982Q51730411-8D2D618C-70B1-44B7-BB9F-EB6CFEB2D7E1Q52724995-1AF878A1-A8C8-4D41-BD51-E39CD377ED66Q57369252-5D36B358-796E-4BC5-8E6B-9482D1AC96C5Q58646940-28C26B62-A3FE-4D96-BDCB-C0B81AAD7715Q58790935-CC3E2308-E04F-4862-8528-637D06BD11EE
P2860
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@en
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@nl
type
label
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@en
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@nl
prefLabel
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@en
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@nl
P2093
P2860
P1433
P1476
Trends in Upstream and Downstream Process Development for Antibody Manufacturing.
@en
P2093
Jochen Strube
Petra Gronemeyer
Reinhard Ditz
P2860
P304
P356
10.3390/BIOENGINEERING1040188
P577
2014-10-01T00:00:00Z